Cargando...
Population Pharmacokinetics of Revefenacin in Patients with Chronic Obstructive Pulmonary Disease
BACKGROUND AND OBJECTIVES: Revefenacin is a lung-selective, long-acting muscarinic antagonist indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease. The objectives of this analysis were to evaluate the pharmacokinetics of revefenacin and its major metabolite...
Gardado en:
| Publicado en: | Clin Pharmacokinet |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Springer International Publishing
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7932972/ https://ncbi.nlm.nih.gov/pubmed/33124005 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40262-020-00938-3 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|